{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T12:56:27Z","timestamp":1774270587032,"version":"3.50.1"},"reference-count":32,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T00:00:00Z","timestamp":1236297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Colorectal Disease"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> The aim of this study was to systematically review all published evidence to determine the efficacy and safety of injectable bulking agents for passive faecal incontinence (FI) in adults.<\/jats:p><jats:p><jats:bold>Method\u2002<\/jats:bold> Electronic searches were performed for MEDLINE, EMBASE, ISI Web of Knowledge and other relevant databases. Hand searching of relevant conference proceedings was undertaken. Studies were considered if they met the predefined inclusion criteria of more than ten adult patients and receiving an injectable bulking agent for passive FI with a validated means of assessing preoperative and postoperative incontinence.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Thirteen case series studies and one randomized placebo\u2010controlled trial (RCT) were included with a total of 420 patients. Two completed RCTs with placebo control were identified but results were unobtainable. Coaptite, Contigen, Durasphere, EVOH and PTQ injections were assessed with 24, 73, 83, 21 and 208 patients respectively. Most studies reported a statistically significant improvement in incontinence scores and quality of life. No statistically significant difference was found between the treatment and placebo arms in the RCT. No serious adverse events were reported.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Currently there is little evidence for the effectiveness of injectable bulking agents in managing passive FI. The inability to obtain results from two further RCTs concerned the reviewers and hindered their ability to make strong recommendations. The identified injectable bulking agents appear to be safe with only minor complications reported.<\/jats:p>","DOI":"10.1111\/j.1463-1318.2009.01828.x","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T07:52:27Z","timestamp":1236325947000},"page":"296-303","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Systematic review on the efficacy and safety of injectable bulking agents for passive faecal incontinence"],"prefix":"10.1111","volume":"12","author":[{"given":"C.","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. B.","family":"Samaranayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. D.","family":"Plank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. P.","family":"Bissett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,11]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"AltomareDF editor.Consensus conference \u2013 treatment options for fecal incontinence. 7th International Meeting of Coloproctology. Saint Vincent October2002.http:\/\/www.colorep.it\/Rivista%20CEC\/consensus_conference.htm[last accessed January 2008]."},{"key":"e_1_2_6_3_2","article-title":"The community prevalence of fecal incontinence: a New Zealand cross\u2010sectional study","volume":"51","author":"Sharma A","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.010"},{"key":"e_1_2_6_5_2","first-page":"322","article-title":"Incontinence in institutions: costs and contributing factors","volume":"147","author":"Borrie MJ","year":"1992","journal-title":"CMAJ"},{"key":"e_1_2_6_6_2","volume-title":"Incontinence. 2nd International Consultation on Incontinence","author":"Donovan J","year":"2002"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02237.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0315"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.013"},{"key":"e_1_2_6_10_2","first-page":"33","article-title":"Epidemiology of fecal incontinence: the silent affliction","volume":"91","author":"Johanson JF","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03293.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4997"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-0760-3"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02234337"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.1.77"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2005.02.004"},{"key":"e_1_2_6_17_2","volume-title":"Statistical Methods for Research Workers","author":"Fisher RA","year":"1941"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2007.01276.x"},{"key":"e_1_2_6_19_2","first-page":"355","article-title":"Efficacia dell\u2019agente PTQ nel trattamento dell\u2019incontinenza fecale","volume":"59","author":"Gaj F","year":"2007","journal-title":"Chir Ital"},{"key":"e_1_2_6_20_2","first-page":"612","article-title":"Injectable silicone for passive faecal Incontinence secondary to internal anal sphincter dysfunction","volume":"47","author":"Lindsey I","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"e_1_2_6_21_2","first-page":"612","article-title":"Trans\u2010sphincteric injection of silicone biomaterial in the treatment of fecal incontinence due to internal anal sphincter defects","volume":"47","author":"Jorge JM","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2008.01544.x"},{"issue":"3","key":"e_1_2_6_23_2","first-page":"50","article-title":"Injectables with special regard to Durasphere for the treatment of fecal incontinence","volume":"9","author":"Aigner F","year":"2007","journal-title":"Colorectal Dis"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-007-9170-7"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01668.x"},{"issue":"2","key":"e_1_2_6_26_2","first-page":"57","article-title":"Durasphere injection under EAUS guidance: management of faecal incontinence","volume":"8","author":"Irukulla S","year":"2006","journal-title":"Colorectal Dis"},{"key":"e_1_2_6_27_2","first-page":"565","article-title":"Initial clinical results using Coaptite\u00ae for the treatment of fecal incontinence","volume":"47","author":"Ezio G","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.5394"},{"issue":"1","key":"e_1_2_6_29_2","first-page":"99","article-title":"Implantation of ethylene\u2010vinyl\u2010alcohol copolymer into the anal intersphincteric plane for management of faecal incontinence: a pilot study","volume":"7","author":"Farmer KC","year":"2005","journal-title":"Colorectal Dis"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02235272"},{"key":"e_1_2_6_31_2","volume-title":"Injectable bulking agents for faecal incontinence","author":"International Procedures Advisory Committee","year":"2007"},{"key":"e_1_2_6_32_2","volume-title":"Intersphincteric injection of silicone biomaterial for severe passive faecal incontinence","author":"Medical Services Advisory Committee","year":"2006"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-007-9009-2"}],"container-title":["Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1318.2009.01828.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1463-1318.2009.01828.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T14:11:28Z","timestamp":1698761488000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1463-1318.2009.01828.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,11]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1463-1318.2009.01828.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1318.2009.01828.x","archive":["Portico"],"relation":{},"ISSN":["1462-8910","1463-1318"],"issn-type":[{"value":"1462-8910","type":"print"},{"value":"1463-1318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,11]]},"assertion":[{"value":"2010-03-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}